FDA Weighs Approval of New Novavax Vaccine | EWTN News Nightly

About this sermon

The FDA is currently weighing a new option for a COVID vaccine. Novavax shots could alleviate some religious freedom concerns since they are not derived from aborted baby cells.The shots also offer a more traditional technology, like the type used in vaccines to prevent shingles. This is in contrast to the mRNA technology used in the Pfizer and Moderna vaccines. Joseph Meaney, president of the National Catholic Bioethics Center, joins EWTN News Nightly to discuss topics surrounding the new vaccine. Additionally, Meaney also discusses the recent news that Senate Democrats are urging President Biden to issue an executive order to give Americans access to abortions. EWTN News Nightly provides the latest news and analysis from a Catholic perspective. Join host Tracy Sabol, our Capitol Hill, White House and Rome Correspondents, as well as many other diverse guests daily, to get the latest from the U.S. and the Vatican on topics regarding our Catholic faith and interests. ------------- EWTN News Nightly airs on EWTN weekdays at 6pm & 9pm ET. ------------ Don't miss an episode of EWTN New Nightly. Get updates here: https://www.ewtn.com/tv/shows/ewtn-news-nightly ------------- Sign up today to receive the EWTN News Nightly newsletter: https://www.ewtn.com/enn ------------- Follow EWTN News Nightly on Social Media: Facebook: https://www.facebook.com/ewtnnewsnightly Twitter: https://twitter.com/EWTNNewsNightly Instagram: https://www.instagram.com/ewtnnewsnightly/ ------------- Subscribe to EWTN YouTube channel here: https://www.youtube.com/user/EWTN ------------- You can support the EWTN News mission: https://bit.ly/3qDR1qf